Daryl C Pope

Array ( [id] => 1355808 [patent_doc_number] => 06576624 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-10 [patent_title] => 'Use of dopamine receptor antagonists in palliative tumor therapy' [patent_app_type] => B1 [patent_app_number] => 09/599561 [patent_app_country] => US [patent_app_date] => 2000-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 1486 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576624.pdf [firstpage_image] =>[orig_patent_app_number] => 09599561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1414995 [patent_doc_number] => 06525082 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Apoptosis inducer' [patent_app_type] => B1 [patent_app_number] => 09/581087 [patent_app_country] => US [patent_app_date] => 2000-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 19069 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/525/06525082.pdf [firstpage_image] =>[orig_patent_app_number] => 09581087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1508117 [patent_doc_number] => 06441029 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Method of suppressing tumor growth with combinations of isoprenoids and statins' [patent_app_type] => B1 [patent_app_number] => 09/587737 [patent_app_country] => US [patent_app_date] => 2000-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8668 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/441/06441029.pdf [firstpage_image] =>[orig_patent_app_number] => 09587737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1360688 [patent_doc_number] => 06573290 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'DFMO and celecoxib in combination for cancer chemoprevention and therapy' [patent_app_type] => B1 [patent_app_number] => 09/573089 [patent_app_country] => US [patent_app_date] => 2000-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 10675 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573290.pdf [firstpage_image] =>[orig_patent_app_number] => 09573089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1460047 [patent_doc_number] => 06391885 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives' [patent_app_type] => B1 [patent_app_number] => 09/564196 [patent_app_country] => US [patent_app_date] => 2000-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13909 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 335 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391885.pdf [firstpage_image] =>[orig_patent_app_number] => 09564196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1551183 [patent_doc_number] => 06399649 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Compositions and methods for the treatment of chronic lymphocytic leukemia' [patent_app_type] => B1 [patent_app_number] => 09/423349 [patent_app_country] => US [patent_app_date] => 2000-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 26 [patent_no_of_words] => 7902 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399649.pdf [firstpage_image] =>[orig_patent_app_number] => 09423349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383152 [patent_doc_number] => 06277835 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Method of tumor treatment' [patent_app_type] => 1 [patent_app_number] => 9/558786 [patent_app_country] => US [patent_app_date] => 2000-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12247 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 274 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277835.pdf [firstpage_image] =>[orig_patent_app_number] => 558786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383773 [patent_doc_number] => 06262078 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Phenoxymethyl piperidine derivatives for the treatment of neuropathic pain' [patent_app_type] => 1 [patent_app_number] => 9/556130 [patent_app_country] => US [patent_app_date] => 2000-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15338 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262078.pdf [firstpage_image] =>[orig_patent_app_number] => 556130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1514815 [patent_doc_number] => 06420378 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Inhibition of abnormal cell proliferation with camptothecin and combinations including the same' [patent_app_type] => B1 [patent_app_number] => 09/553710 [patent_app_country] => US [patent_app_date] => 2000-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8341 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420378.pdf [firstpage_image] =>[orig_patent_app_number] => 09553710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4326419 [patent_doc_number] => 06329355 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Method for inhibiting the growth of cancers' [patent_app_type] => 1 [patent_app_number] => 9/552408 [patent_app_country] => US [patent_app_date] => 2000-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3320 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329355.pdf [firstpage_image] =>[orig_patent_app_number] => 552408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636414 [patent_doc_number] => 06380245 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Antibiotics TKR1912-I and TKR1912-II and process for producing the same' [patent_app_type] => B1 [patent_app_number] => 09/550053 [patent_app_country] => US [patent_app_date] => 2000-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 4589 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380245.pdf [firstpage_image] =>[orig_patent_app_number] => 09550053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1397346 [patent_doc_number] => 06541495 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Carboxylic acid derivatives as inhibitors of hyperproliferation diseases' [patent_app_type] => B1 [patent_app_number] => 09/548937 [patent_app_country] => US [patent_app_date] => 2000-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5198 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541495.pdf [firstpage_image] =>[orig_patent_app_number] => 09548937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4328840 [patent_doc_number] => 06319915 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Benzazepine derivatives as inhibitors of hyperproliferation diseases' [patent_app_type] => 1 [patent_app_number] => 9/548194 [patent_app_country] => US [patent_app_date] => 2000-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9579 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1335 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319915.pdf [firstpage_image] =>[orig_patent_app_number] => 548194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575352 [patent_doc_number] => 06469045 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Methods and compositions for inhibition of angiogenesis with EM-138' [patent_app_type] => B1 [patent_app_number] => 09/545139 [patent_app_country] => US [patent_app_date] => 2000-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6826 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469045.pdf [firstpage_image] =>[orig_patent_app_number] => 09545139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1286448 [patent_doc_number] => 06638974 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Ascorbyl esters for the treatment of cancer' [patent_app_type] => B1 [patent_app_number] => 09/544693 [patent_app_country] => US [patent_app_date] => 2000-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 33 [patent_no_of_words] => 9064 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638974.pdf [firstpage_image] =>[orig_patent_app_number] => 09544693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4338187 [patent_doc_number] => 06333348 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Use of docetaxel for treating cancers' [patent_app_type] => 1 [patent_app_number] => 9/544176 [patent_app_country] => US [patent_app_date] => 2000-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3899 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333348.pdf [firstpage_image] =>[orig_patent_app_number] => 544176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1399063 [patent_doc_number] => 06531482 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-11 [patent_title] => 'Method and compositions for maintaining glomerular filtration rate while inhibiting extracellular matrix accumulation' [patent_app_type] => B1 [patent_app_number] => 09/542314 [patent_app_country] => US [patent_app_date] => 2000-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 5696 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531482.pdf [firstpage_image] =>[orig_patent_app_number] => 09542314 [rel_patent_id] =>[rel_patent_doc_number] =>)